Markit, a global provider of financial information services, announced today that it has chosen Wall Street Horizon (WSH) to supply corporate events data to Markit Hub. Markit Hub aggregates research, analysis and news content from global banks, information providers and news agencies.
Accurate corporate events data is an increasingly important part of buyside firms’ toolkits.
Markit Hub clients will now be able to gain access to WSH’s acclaimed forward-looking and historical corporate events datasets, providing information to help professionals manage risk, understand price movement, avoid volatility, and generate alpha. According to WSH’s 2016 Corporate Event Research Survey, accurate corporate events data is an increasingly important part of buyside firms’ toolkits.
Tom Conigliaro, managing director of Trading Services at Markit, commented: “Markit Hub was created to aggregate the most relevant and high-quality research and data necessary for users to operate effectively on a day-to-day basis. With the addition of Wall Street Horizon’s events data, customers will be finely tuned to less visible, but increasingly vital indicators.”
Stocks to Watch This Week – Expedia Group, IncGo to article >>
Markit Hub provides a centralised interface for managing sellside and independent research, industry content, economic research, company fundamentals and filings. Over 20,000 financial market professionals, representing over 14,000 investment firms, use Markit Hub to access research, news and data from global banks, news and third-party research providers.
“Corporate events can have a significant impact on investment strategy, timing and outcome,” said Bruce Fador, president and CCO of Wall Street Horizon. “Markit’s recognition of the value in adding our forward looking event dates lends further credence to its importance to investors. We’re thrilled to partner with Markit to make our unique data offerings available to such an influential user base.”
Finance Magnates reported on Markit earlier this month after the company agreed to acquire Prism Valuation, complementing its portfolio valuations service while enabling the company to offer its clients enhanced coverage of complex OTC derivatives and structured OTC products.